Oncology

Content will be added shortly.

Sl No. Title Authors Journal Name Publication Year
1 Progress in psycho-oncology with special reference to developing countries Murthy RS, Alexander A Curr Opin Psychiatry 2019
2 Stromal cells downregulate miR-23a-5p to activate protective autophagy in acute myeloid leukemia Ganesan S, Palani HK, Lakshmanan V, Balasundaram N, Alex AA, David S, Venkatraman A, Korula A, George B, Balasubramanian P, Palakodeti D, Vyas N, Mathews V Cell Death Dis 2019
3 A smart tele-cytology point-of-care platform for oral cancer screening Sunny S, Baby A, James BL, Balaji D, N V A, Rana MH, Gurpur P, Skandarajah A, D'Ambrosio M, Ramanjinappa RD, Mohan SP, Raghavan N, Kandasarma U, N S, Raghavan S, Hedne N, Koch F, Fletcher DA, Selvam S, Kollegal M, N PB, Ladic L, Suresh A, Pandya HJ, Kuriakose MA PLoS One 2019
4 The impact of breast cancer on the patient and the family in Indian perspective Alexander A, Kaluve R, Prabhu JS, Korlimarla A, Srinath BS, Manjunath S, Patil S, Gopinath KS, Sridhar TS Indian J Palliat Care 2019
5 HR+HER2- breast cancers with growth factor receptor-mediated EMT have a poor prognosis and lapatinib downregulates EMT in MCF-7 cells Desai K, Aiyappa R, Prabhu JS, Nair MG, Lawrence PV, Korlimarla A, CE Anupama, Alexander A, Kaluve RS, Manjunath S, Correa M, Srinath BS, Patil S, Kalamdani A, Prasad M, Sridhar TS Tumour Biology 2017
6 Dissecting the Biological Heterogeneity within Hormone Receptor Positive HER2 Negative Breast Cancer by Gene Expression Markers Identifies Indolent Tumors within Late Stage Disease Prabhu JS, Korlimarla A, Anupama CE, Alexander A, Raghavan R, Kaul R, Desai K, Rajarajan S, Manjunath S, Correa M, Raman R, Kalamdani A, Prasad M, Patil S, Gopinath KS, Srinath BS, Sridhar TS Translational Oncology 2017
7 Analysis of Clinico-Pathological Characteristics of Indian Breast CancersShows Conservation of Specific Features in the Hormone Receptor Sub-Types Mukherjee G, Lakshmaiah KC, Vijayakumar M, Prabhu JS, Telikicherla D, Sridhar TS, Kumar RV Journal of Integrative Oncology 2016
8 High expression of integrin beta6 in association with the Rho-Rac pathway identifies a poor prognostic subgroup within HER2 amplified breast cancers Desai K, Nair MG, Prabhu JS, Vinod A, Korlimarla A, Rajarajan S, Aiyappa R, Kaluve RS, Alexander A, Hari PS, Mukherjee G, Kumar RV, Manjunath S, Correa M, Srinath BS, Patil S, Prasad MS, Gopinath KS, Rao RN, Violette SM, Weinreb PH, Sridhar TS Cancer Medicine 2016
9 Beta3 integrin promotes chemoresistance to epirubicin in MDA-MB-231 through repression of the pro-apoptotic protein, BAD Nair MG, Desai K, Prabhu JS, Hari PS, Remacle J, Sridhar TS Experimental Cell Research 2016
10 Data on alteration of hormone and growth factor receptor profiles over progressive passages of breast cancer cell lines representing different clinical subtypes Nair MG, Desai K, Prabhu JS, Hari PS, Remacle J, Sridhar TS Data in Brief 2016
11 A Majority of Low (1-10%) ER Positive Breast Cancers Behave Like Hormone Receptor Negative Tumors Prabhu JS, Korlimarla A, Desai K, Alexander A, Raghavan R, Anupama C, Dendukuri N, Manjunath S, Correa M, Raman N, Kalamdani A, Prasad M, Gopinath KS, Srinath BS, Sridhar TS Journal of Cancer 2014
12 Separate quality-control measures are necessary for estimation of RNA and methylated DNA from formalin-fixed, paraffin-embedded specimens by quantitative PCR Korlimarla A, Prabhu JS, Anupama CE, Remacle J, Wahi K, Sridhar TS J Mol Diagn 2014
13 Cancer research in India: national priorities, global results. Sullivan R, Badwe RA, Rath GK, Pramesh CS, Shanta V, Digumarti R, D'Cruz A, Sharma SC, Viswanath L, Shet A, Vijayakumar M, Lewison G, Chandy M, Kulkarni P, Bardia MR, Kumar S, Sarin R, Sebastian P, Dhillon PK, Rajaraman P, Trimble EL, Aggarwal A, Vijaykum Lancet Oncol 2014
14 Identification of a non-canonical nuclear localization signal (NLS) in BRCA1 that could mediate nuclear localization of splice variants lacking the classical NLS Korlimarla A, Bhandary L, Prabhu JS, Shankar H, Sankaranarayanan H, Kumar P, Remacle J, Natarajan D, Sridhar TS Cellular & Molecular Biology Letters 2013
15 The epigenetic silencing of the estrogen receptor (ER) by hypermethylation of the ESR1 promoter is seen predominantly in triple-negative breast cancers in Indian women Prabhu JS, Wahi K, Korlimarla A, Correa M, Manjunath S, Raman N, Srinath BS, Sridhar TS Tumour Biology 2012